The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk
Open accessAbstract
Background Individuals at clinical high risk (CHR) who progress to fully psychotic symptoms have been observed to show a steeper rate of cortical gray matter reduction compared with individuals without symptomatic progression and with healthy control subjects. Whether such changes reflect processes associated with the pathophysiology of schizophrenia or exposure to antipsychotic drugs is unknown. Methods In this multisite study, 274 CHR cases, including 35 individuals who converted to psychosis, and 135 healthy comparison subjects were scanned with magnetic resonance imaging at baseline, 12-month follow-up, or the point of conversion for the subjects who developed fully psychotic symptoms. Results In a traveling subjects substudy, excellent reliability was observed for measures of cortical thickness and subcortical volumes. Controlling for multiple comparisons throughout the brain, CHR subjects who converted to psychosis showed a steeper rate of gray matter loss in the right superior frontal, middle frontal, and medial orbitofrontal cortical regions as well as a greater rate of expansion of the third ventricle compared with CHR subjects who did not convert to psychosis and healthy control subjects. Differential tissue loss was present in subjects who had not received antipsychotic medications during the interscan interval and was predicted by baseline levels of an aggregate measure of proinflammatory cytokines in plasma. Conclusions These findings demonstrate that the brain changes are not explained by exposure to antipsychotic drugs but likely play a role in psychosis pathophysiology. Given that the cortical changes were more pronounced in subjects with briefer durations of prodromal symptoms, contributing factors may predominantly play a role in acute-onset forms of psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Schizophrenia is associated with accelerated gray matter loss in PFC (Cannon, Chung, He, Sun, Jacobson, van Erp, & Consortium, 2014), including loss of dendrites and spines in the dlPFC (Glantz & Lewis, 2000).”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Cannon et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, there is loss of dlPFC gray matter in schizophrenia4,5 and Alzheimer’s disease6, while changes in more ventral and medial PFC regions are evident in mood disorders7 and in post-traumatic-stress disorder (PTSD)8.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the onset of schizophrenia is accompanied by waves of PFC gray matter loss, as well as increased signs of inflammation5.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the onset of schizophrenia is accompanied by waves of PFC gray matter loss, as well as increased signs of inflammation5.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As guanfacine is approved by the US Food and Drug Administration for use in adolescents103, it may offer a practical approach for reducing the inflammatory response and gray matter loss found in prodromal schizophrenia5.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rao, J. S., Kim, H.-W., Harry, G. J., Rapoport, S. I., & Reese, E. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.017 · Cited by 106
RetractedCortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B. R., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,995
Automatically Parcellating the Human Cerebral Cortex
Fischl, B. R. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg087 · Cited by 4,208
Within-subject template estimation for unbiased longitudinal image analysis
Reuter, M., Schmansky, N. J., Rosas, H. D., & Fischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.084 · Cited by 2,356
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,056
Self-citationHighly accurate inverse consistent registration: A robust approach
Reuter, M., Rosas, H. D., & Fischl, B. R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.07.020 · Cited by 1,443
Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
Feinberg, I. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90038-3 · Cited by 1,395
Cited by
Sorted by citations
Items 401–500 of 600
Rasser, P. E., Ehlkes, T., MinT Consortium, & Schall, U. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05494-9 · Cited by 7
Cognitive Enhancement in Schizophrenia and Related Disorders
Keshavan, M. S., & Eack, S. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108163682 · Cited by 7
Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?
Rubio, J. M., & Pérez-Rodríguez, M. M. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac059 · Cited by 7
Sefik, E., Boamah, M., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Keshavan, M. S., Mathalon, D. H., Perkins, D. O., Stone, W. S., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac169 · Cited by 7
Self-citationBannai, D., Reuter, M., Hegde, R. R., Hoang, D. T., Adhan, I. K., Gandu, S., Pong, S., Raymond, N., Zeng, V., Chung, Y., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.021 · Cited by 7
Self-citationBasic symptoms and gray matter volumes of patients at clinical high risk for psychosis
Hubl, D., Michel, C., Schultze‐Lutter, F., Hauf, M., SCHIMMELMANN, B. G., Kaess, M., & Kindler, J. (2020) · Psychological Medicine · doi:10.1017/s0033291720001282 · Cited by 7
Using Two- and Three-Dimensional Human iPSC Culture Systems to Model Psychiatric Disorders
Christian, K. M., Song, H., & Ming, G. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_9 · Cited by 8
Shah, J. L., Chakravarty, M. M., Joober, R., & Lepage, M. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.160053 · Cited by 9
Endothelial PD‐1 Regulates Vascular Homeostasis and Oligodendrogenesis during Brain Development
He, T., Zhang, M., Qin, J., Wang, Y., Li, S., Du, C., Jiao, J., & Ji, F. (2025) · Advanced Science · doi:10.1002/advs.202417410 · Cited by 7
Dissecting the impact of complement component 4A in bipolar disorder
Hörbeck, E., Jönsson, L., Malwade, S., Karlsson, R., Pålsson, E., Sigström, R., Sellgren, C. M., & Landén, M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.006 · Cited by 6
Hua, J. P. Y., Karcher, N. R., Straub, K. T., & Kerns, J. G. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00479-8 · Cited by 7
Fortea, A., van Eijndhoven, P., Ilzarbe, D., Batalla, A., Calvet-Mirabent, À., de la Serna, E., Puig, O., Castro‐Fornieles, J., Dolz, M., Tor, J., et al. (2023) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2023.01.001 · Cited by 6
Compensatory thickening of cortical thickness in early stage of schizophrenia
Wang, Y., Fan, L., He, Y., Yuan, L., Li, Z., Zheng, W., Tang, J., Li, C., Jin, K., Liu, W., et al. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae255 · Cited by 7
Rosengard, R., Makowski, C., Chakravarty, M. M., MALLA, A. K., Joober, R., Shah, J. L., & Lepage, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109879 · Cited by 6
Neuroimaging studies in people at clinical high risk for psychosis
Gifford, G., McCutcheon, R. A., & McGuire, P. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00009-0 · Cited by 7
Improving Therapeutic Interventions of Schizophrenia with Advances in Stem Cell Technology
Espejo, J. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.3.352 · Cited by 6
Evermann, U., Schmitt, S., Meller, T., Pfarr, J., Grezellschak, S., & Nenadić, I. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01229-5 · Cited by 7
Kirschner, M., Hodzic-Santor, B. H., Antoniades, M., Nenadić, I., Kircher, T. T. J., Krug, A., Fornito, A., Arnatkevičiūtė, A., Dannlowski, U., DeRosse, P., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.463 · Cited by 6
Network Dysconnectivity: A Psychosis-Triggering Mechanism?
Cannon, T. D. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.019 · Cited by 6
Self-citationCadenhead, K. S., & Mirzakhanian, H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15060789 · Cited by 6
Self-citationNetwork-based spreading of grey matter changes across different stages of psychosisPreprint
Chopra, S., Segal, A., Oldham, S., Holmes, A., Sabaroedin, K., Orchard, E. R., Francey, S. M., O'Donoghue, B. N., Cropley, V., Nelson, B., et al. (2022) · medRxiv · doi:10.1101/2022.01.11.22268989 · Cited by 6
Karcher, N. R., Dong, F., Paul, S. E., Johnson, E. C., Kilçiksiz, C. M., Oh, H. Y., Schiffman, J. E., Arpana Agrawal, A., Bogdan, R., Jackson, J. J., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00481-9 · Cited by 7
Synergistic pathways to psychosis: understanding developmental risk and resilience factors
O’Brien, K. J., Huque, Z. M., Pike, M. R., Smith, E. C., Davies, N. L., & Ellman, L. M. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02261-6 · Cited by 12
Okesanya, O. J., Adebayo, U. O., Ngwoke, I., Agboola, A. O., Atewologun, F. A., Ajayi, S. B., Olaleke, N. O., Oso, T. A., & Lucero‐Prisno, D. E. (2025) · Exploration of Digital Health Technologies · doi:10.37349/edht.2025.101174 · Cited by 6
Karcher, N. R., Merchant, J. T., Rappaport, B. I., & Barch, D. M. (2023) · Journal of Psychopathology and Clinical Science · doi:10.1037/abn0000820 · Cited by 6
Cadenhead, K. S., Kennedy, L., Mirzakhanian, H., Addington, J., Bearden, C. E., Cannon, T. D., Carrión, R. E., Keshavan, M. S., Mathalon, D. H., Perkins, D. O., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf133 · Cited by 5
Self-citationThe Role of the Corpus Callosum in Psychosis.
McGuire, P. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.021 · Cited by 4
Chagnon, Y. C., Maziade, M., Paccalet, T., Croteau, J., Fournier, A., Roy, M., & Bureau, A. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0526-y · Cited by 6
Effect of schizophrenia risk gene polymorphisms on cognitive and neural plasticity
Zhao, W., Zhang, Q.-M., Su, Y., Chen, X., Li, X., Du, B., Deng, X., Ji, F., Li, J., Dong, Q., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.08.014 · Cited by 6
Rethinking Immunity and Cognition in Clinical High Risk for Psychosis
Griffiths, S. L., Upthegrove, R., Zuelli, F. M. D. G. C., & Deakin, J. F. W. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_399 · Cited by 5
Shovestul, B. J., Scharf, M., Liu, G., & Dodell‐Feder, D. (2023) · Psychiatry Research Communications · doi:10.1016/j.psycom.2023.100149 · Cited by 7
Curtis, M. T., Sklar, A. L., Coffman, B. A., & Salisbury, D. F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1114703 · Cited by 5
Joo, S. W., Jo, Y. T., Kim, Y., Lee, W. H., Chung, Y., & Lee, J. S. (2023) · Psychological Medicine · doi:10.1017/s0033291723001988 · Cited by 5
Self-citationA computational framework for cancer response assessment based on oncological PET-CT scans
Sampedro, F., Escalera, S., Domènech, A., & Carrió, I. (2014) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2014.10.014 · Cited by 5
Miklowitz, D. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.09.006 · Cited by 5
Cao, H., Chung, Y., McEwen, S. C., Bearden, C. E., Addington, J., Goodyear, B. G., Cadenhead, K. S., Mirzakhanian, H., Cornblatt, B. A., Olvet, D. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/179242 · Cited by 5
Self-citationHamilton, H., Roach, B. J., Bachman, P., Belger, A., Carrión, R. E., Duncan, E., Johannesen, J., Light, G. A., Niznikiewicz, M. A., Addington, J., et al. (2024) · Clinical EEG and Neuroscience · doi:10.1177/15500594241294035 · Cited by 4
Self-citationThe influence of deprivation on cortical development and psychotic symptoms in youth
Thomas, M., Whittle, S., & Cropley, V. (2025) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.14150 · Cited by 4
Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia
Sapienza, J., Spangaro, M., Comai, S., Sabé, M., Torre, J. T. L., Buonarroti, M., Cavallaro, R., & Bosia, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188949 · Cited by 5
Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research
Schvarcz, A., & Bearden, C. E. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0033-6 · Cited by 5
Self-citationGangadin, S. S., van der Weijden-Germann, M., de Witte, L. D., Gelderman, K. A., Mandl, R. C. W., & Sommer, I. E. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.08.031 · Cited by 4
Digital Loneliness in Social Media: The Epoch of our Connected and Distraction World
Amin, Z., & Zinaida, R. S. (2024) · Contributions to management science · doi:10.1007/978-3-031-48770-5_65 · Cited by 7
Gao, W., Mu, Q., Cui, D., Zhu, C., Jiao, Q., Su, L., Lu, S., & Yang, R. (2025) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2025.111948 · Cited by 4
Sun, L., Wang, Z., & Fang, J. (2023) · Springer eBooks · doi:10.1007/978-981-19-9902-4_15 · Cited by 4
Melazzini, L., Mazzocchi, L., Vecchio, A., Paredes, A., Mensi, M. M., Ballante, E., Paoletti, M., Bastianello, S., Balottin, U., Borgatti, R., et al. (2023) · Neuroradiology · doi:10.1007/s00234-023-03200-2 · Cited by 4
Cross-modal associative memory impairment in schizophrenia
Gao, T., Wang, X., Cen, H., Li, X., Zhai, Z., Lu, C., Dong, Y., Zhang, S., Zhuo, K., Xiang, Q., et al. (2023) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2023.108721 · Cited by 4
Reinventing schizophrenia: The rules of the game
McCutcheon, R. A., & McGuire, P. K. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2021.12.009 · Cited by 4
Schizophrenia polygenic risk during typical development reflects multiscale cortical organizationPreprint
Kirschner, M., Paquola, C., Khundrakpam, B. S., Vainik, U., Bhutani, N., Hodzic-Santor, B. H., Georgiadis, F., Al‐Sharif, N., Mišić, B., Bernhardt, B. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.13.448243 · Cited by 4
Kynurenic acid inflammatory signaling expands in primates and impairs prefrontal cortical cognitionPreprint
Yang, S., Datta, D., Krienen, F. M., Ling, E., Woo, E., May, A., Anderson, G., Galvin, V. C., González‐Burgos, G., Lewis, D. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.13.598842 · Cited by 4
van der Heijden, H. C., Hamoda, H. M., Ray, A., Goldman, M., Golden, M. J., Graber, K. M., Duffy, F. H., D’Angelo, E. J., Gagoski, B. A., Yekedüz, M. K., et al. (2025) · The Cerebellum · doi:10.1007/s12311-025-01822-1 · Cited by 3
Nóbrega, I. D. S., Moysés, M. B. B., Yokota-Moreno, B. Y., Ferreira, G. G., Cebinelli, G. M., & Sertié, A. L. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107065 · Cited by 3
Merritt, K., Palmer, E. R., Laguna, P. A. L., Sethi, A., Rogers, J. C., Evans, C. J., Reichenberg, A., Khandaker, G. M., Upthegrove, R., Lewis, G., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106247 · Cited by 3
Biomarkers for predicting transition from at-risk mental state to psychosis: A systematic review
Ricci, V., Martinotti, G., Mosca, A., & Maina, G. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106612 · Cited by 3
The Early Visual System in Schizophrenia
Silverstein, S. M., & Butler, P. D. (2026) · Annual Review of Vision Science · doi:10.1146/annurev-vision-110425-125244 · Cited by 3
Kenney, J. P. M., Rueda‐Delgado, L. M., Hanlon, E. O., Jollans, L., Kelleher, I., Healy, C., Dooley, N., McCandless, C., Frodl, T., Leemans, A., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102983 · Cited by 3
The Influence of Gut Microbiota in Psychosis
Murray, N., Ghomi, R. H., Nemani, K., & O’Connor, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00018-7 · Cited by 3
Promising Advances in Schizophrenia Treatment
Shukla, R., Hirpara, D., Sagar, K., & Rajpura, A. (2024) · Journal of Pharma Insights and Research. · doi:10.69613/v5mv2h28 · Cited by 5
Li, Y., Gui, Q.-Q., Ren, S., Liu, Z., Zhang, A.-X., Liu, P.-H., Zhou, X.-P., Sun, N., & Yang, C.-X. (2025) · Brain and Behavior · doi:10.1002/brb3.70442 · Cited by 1
Computational Neuroanatomy of Schizophrenia
Davatzikos, C. A., & Koutsouleris, N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00023-9 · Cited by 3
Keshavan, M. S., & Eack, S. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108163682.004 · Cited by 3
Endophenotypes in psychiatric genomics: a selective review of their status and a call to action
Diehl, C., Rockstroh, B. S., Yee, C. M., & Miller, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819602-1.00020-6 · Cited by 3
Tor, J., Baeza, I., Sintes-Estevez, A., de la Serna, E., Puig, O., Muñoz-Samons, D., Álvarez-Subiela, J., Sugranyes, G., & Dolz, M. (2023) · European Child and Adolescent Psychiatry · doi:10.1007/s00787-022-02137-w · Cited by 3
l-ficolin-MASP arm of the complement system in schizophrenia
Mayilyan, K. R., Krarup, A., Soghoyan, A. F., Jensenius, J. C., & Sim, R. B. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152349 · Cited by 3
The immunopsychiatry of early-onset psychosis
Wedervang‐Resell, K., & Szabó, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89832-4.00013-5 · Cited by 3
Holton, K. M., Chan, S. Y., Brockmeier, A. J., Öngür, D., & Hall, M. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120127 · Cited by 3
Familial Mediterranean fever association with schizophrenia: insights from big data analysis
Sharif, Κ., Watad, ., Bragazzi, N. L., Yavne, Y., Bridgewood, C., McGonagle, D., Comanhester, D., Cohen, A. D., & Amital, H. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.95463 · Cited by 3
Waltzman, D., Knowlton, B. J., Cohen, J. R., Bookheimer, S. Y., Bilder, R. M., & Asarnow, R. F. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.10.010 · Cited by 3
Neurodevelopmental Theories of Schizophrenia: Twenty‐First Century Perspectives
Haut, K. M., Schvarcz, A., Cannon, T. D., & Bearden, C. E. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy223 · Cited by 3
Self-citationMamah, D. T., Mutiso, V., Musyimi, C. W., Harms, M. P., Anokhin, A. P., Chen, S., Torous, J. B., Muyela, L. A., Nashed, J., Al-Hosni, Y., et al. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae009 · Cited by 2
Martinotti, G., Piro, T., Ciraselli, N., Persico, L., Inserra, A., Pettorruso, M., Maina, G., & Ricci, V. (2026) · Brain Science · doi:10.3390/brainsci16010112 · Cited by 4
Chopra, S., Holmes, A., Segal, A., Zhang, X.-H., Francey, S. M., O'Donoghue, B. N., Cropley, V., Nelson, B., Graham, J., Baldwin, L., et al. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.06.028 · Cited by 5
Li, X., Wei, W., Wang, Q., Deng, W., Li, M., Ma, X., Zeng, J., Zhao, L., Guo, W., Hall, M., et al. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae026 · Cited by 2
Differential inflammatory profiles in carriers of reciprocal 22q11.2 copy number variants
O’Hora, K., Amir, C., Chiem, E., Schleifer, C. H., Grigoryan, V., Kushan, L., Chiang, J. J., Cole, S. W., Irwin, M. R., & Bearden, C. E. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107135 · Cited by 2
Self-citationClinical and immunological relationships in patients with early schizophrenia
Serazetdinova, V. S., Петрова, Н. Н., Dorofeykov, V. V., & Mayorova, M. A. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512502135 · Cited by 2
Wong, T. Y., Moore, T. M., Hillman, N., Calkins, M. E., Shahriar, S. S., Dietterich, T. E., Ruparel, K., Roalf, D. R., Wolf, D. H., Satterthwaite, T. D., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf049 · Cited by 2
Neuroimaging: Diagnostic Boundaries and Biomarkers
Galderisi, S., Giordano, G. M., & DeLisi, L. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-97307-4_1 · Cited by 3
Finding Pieces to the Puzzle of Brain Structure in Schizophrenia
Bilder, R. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.003 · Cited by 2
Cortisol and cytokines in early psychosis, do they correlate? A scoping review
Karanikas, E. (2019) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2019.05.002 · Cited by 2
Predicting Outcome in Schizophrenia: Neuroimaging and Clinical Assessments
Andreasen, N. C., & Nickl‐Jockschat, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-35206-6_17 · Cited by 2
Delivering on the public health promise of the psychosis risk paradigm
Cannon, T. D. (2020) · World Psychiatry · doi:10.1002/wps.20785 · Cited by 2
Self-citationKerins, S., Nottage, J. F., de Pablo, G. S., Kempton, M. J., Tognin, S., Nieman, D. H., de Haan, L., van Amelsvoort, T., Kwon, J. S., Nelson, B., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.828376 · Cited by 2
Commentary: Do Complement factors “connect the dots” in schizophrenia?
Lizano, P. L., Prasad, K. M. R., & Keshavan, M. S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.042 · Cited by 2
Dodell‐Feder, D. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 2
Kirschner, M., Hodzic-Santor, B. H., Antoniades, M., Nenadić, I., Kircher, T. T. J., Krug, A., Meller, T., Grotegerd, D., Fornito, A., Arnatkevičiūtė, A., et al. (2021) · medRxiv · doi:10.1101/2021.04.29.21255609 · Cited by 2
Cha, J., Park, J., Cho, M., Lee, E., Kim, B., Kim, G., & Joo, Y. Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4618474/v1 · Cited by 2
Saito, Y., Pantelis, C., Cropley, V., Laskaris, L., Wannan, C., & Syeda, W. T. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103824 · Cited by 1
Zheng, W., Xu, L., Zhang, D. H., Su, W., Wei, Y., Cui, H., Hong, Y., Zhao, J., Tang, X., Qian, Z., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf111 · Cited by 1
Repurposing medications to prevent psychosis
Cohen, B. M., McPhie, D. L., Sonntag, K., Lopes, C., & Babb, S. M. (2025) · npj Mental Health Research · doi:10.1038/s44184-025-00169-z · Cited by 2
Rodriguez-Sanchez, J., Hauke, D. J., Pinotsis, D. A., Berndt, L. C. S., Oloye, H., Nicholas, S., Hamilton, H., Roach, B. J., Bachman, P., Belger, A., et al. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.04.007 · Cited by 3
Self-citationTorii, Y., Sekiguchi, H., Habuchi, C., Miwa, A., Arafuka, S., Takeda, K., Fujishiro, H., Yoshida, M., Iwasaki, Y., Iritani, S., et al. (2026) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.70079 · Cited by 1
Srivastava, K., & Srivastava, R. (2026) · Frontiers in Systems Biology · doi:10.3389/fsysb.2026.1898853 · Cited by 1
Biomarkers of vulnerability and progression in the psychosis prodrome
Cannon, T. D. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.068 · Cited by 1
Self-citationČervenka, S. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.08.004 · Cited by 1
Takayanagi, Y., Kulason, S., Sasabayashi, D., Takahashi, T., Katagiri, N., Sakuma, A., Ohmuro, N., Katsura, M., Nishiyama, S., Kido, M., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab353 · Cited by 1
Which Came First: The Hallucination or the Neural Alteration?
Karcher, N. R. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.029 · Cited by 1
Complement Activation Products in Patients with Chronic Schizophrenia
Rudkowski, K., Waszczuk, K., Tyburski, E. M., Rek-Owodziń, K., Plichta, P., Podwalski, P., Bielecki, M., Mak, M., Michalczyk, A., Tarnowski, M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041577 · Cited by 1
Translational Neuroimaging in Psychiatry
Bellani, M., Rossetti, M. G., Maggioni, E., Crespo‐Facorro, B., & Brambilla, P. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.011 · Cited by 1
Yunzhi, P., Mingjun, Z., Yuqing, C., Lin, H., Weiqing, H., Wenjian, T., Danqing, H., Jun, Y., Yixing, C., & Xudong, C. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111329 · Cited by 1
Cognitive Training in Schizophrenia
Haut, K. M., Mittal, V. A., Shankman, S. A., & Hooker, C. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803457-6.00020-9 · Cited by 1
Vignapiano, A., DeLisi, L. E., & Galderisi, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-97307-4_9 · Cited by 1
Metadata
- Authors
- Cannon, T. D., Chung, Y., He, G., Sun, D., Jacobson, A., van Erp, T. G. M., McEwen, S., Addington, J., Bearden, C. E., Cadenhead, K., Cornblatt, B., Mathalon, D. H., McGlashan, T., Perkins, D., Jeffries, C., Seidman, L. J., Tsuang, M., Walker, E., Woods, S. W., & Heinssen, R.
- Affiliations
- Yale University (US)
- University of California, Los Angeles (US)
- University of California, Irvine (US)
- University of Calgary (CA)
- University of California San Diego (US)
- Zucker Hillside Hospital (US)
- University of California, San Francisco (US)
- University of North Carolina at Chapel Hill (US)
- Beth Israel Deaconess Medical Center (US)
- Emory University (US)
- National Institute of Mental Health (US)
- Corresponding author
- Cannon, Tyrone D.
- ORCID
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 77
- Issue
- 2
- Pages
- 147-157
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC4264996
- OpenAlex
- W2166663076
- Cited by
- 599
- References
- 63
- Citations by year
- 2026: 28 · 2025: 28 · 2024: 38 · 2023: 49 · 2022: 44 · 2021: 73 · 2020: 73 · 2019: 78 · 2018: 38 · 2017: 43 · 2016: 54 · 2015: 44
- FWCI
- 37.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Commonwealth of Massachusetts
- National Institute of Mental Health
- National Institutes of Health (MH081902, MH066160, MH081928, MH081857, MH082004, P50 MH080272, MH081988, P50 MH066286, MH082022, MH081984)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- clinical high risk for psychosis, transition to psychosis, cortical thickness, gray matter loss, schizophrenia pathophysiology, inflammatory cytokines, frontal cortex, prodromal symptoms, youth
- MeSH terms
- Adolescent, Cerebral Cortex, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Organ Size, Psychotic Disorders, Risk, Antipsychotic Agents, Reproducibility of Results, Cytokines, Disease Progression, Young Adult, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
